The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Karlin Daniel since 2022.
This trader's CIK number is 1897618.
At the time of last reporting, Karlin Daniel was the Chief Medical Officer of Definium Therapeutics, Inc.. (stock ticker symbol DFTX).
Also see all insider trading activities at Definium Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2026 | DFTX | 0 | $0 | 8,018 | $148,092 | 0 | $0 |
| 2025 | DFTX | 0 | $0 | 27,988 | $248,331 | 0 | $0 |
| 2024 | DFTX | 0 | $0 | 20,374 | $153,577 | 0 | $0 |
| 2023 | DFTX | 0 | $0 | 24,052 | $83,580 | 0 | $0 |
| 2022 | DFTX | 0 | $0 | 65,846 | $69,487 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2026-03-25 | DFTX | Sale | 8,018 | 18.47 | 148,092 |
| 2025-12-26 | MNMD | Sale | 5,600 | 13.15 | 73,623 |
| 2025-09-25 | MNMD | Sale | 7,704 | 9.77 | 75,268 |
| 2025-06-25 | MNMD | Sale | 7,848 | 6.80 | 53,366 |
| 2025-03-25 | MNMD | Sale | 6,836 | 6.74 | 46,074 |
| 2024-09-25 | MNMD | Sale | 6,871 | 5.98 | 41,088 |
| 2024-06-25 | MNMD | Sale | 6,925 | 7.22 | 49,998 |
| 2024-03-25 | MNMD | Sale | 6,578 | 9.50 | 62,491 |
| 2023-12-26 | MNMD | Sale | 6,774 | 3.63 | 24,589 |
| 2023-09-25 | MNMD | Sale | 6,918 | 3.58 | 24,731 |
| 2023-06-27 | MNMD | Sale | 6,783 | 3.20 | 21,705 |
| 2023-03-01 | MNMD | Sale | 3,577 | 3.51 | 12,555 |
| 2022-10-25 | MNMD | Sale | 541 | 2.81 | 1,520 |
| 2022-10-27 | MNMD | Sale | 644 | 3.00 | 1,932 |
| 2022-09-26 | MNMD | Sale | 565 | 5.51 | 3,113 |
| 2022-09-27 | MNMD | Sale | 640 | 5.87 | 3,756 |
| 2022-08-31 | MNMD | Sale | 1,204 | 11.67 | 14,050 |
| 2022-07-25 | MNMD | Sale | 8,361 | .69 | 5,769 |
| 2022-07-27 | MNMD | Sale | 9,856 | .69 | 6,800 |
| 2022-06-27 | MNMD | Sale | 26,238 | .70 | 18,366 |
| 2022-05-27 | MNMD | Sale | 9,555 | .82 | 7,835 |
| 2022-05-25 | MNMD | Sale | 8,242 | .77 | 6,346 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Karlin Daniel (Chief Medical Officer of Definium Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.